The Aptamers Market is gaining significant momentum worldwide, driven by rapid advancements in biotechnology, molecular diagnostics, and targeted therapeutics. Aptamers — short, single-stranded nucleic acid or peptide molecules — are capable of binding to specific targets such as proteins, peptides, small molecules, and even cells with high affinity and specificity. Their...